Landec Corporation

NASDAQ: LNDC · Real-Time Price · USD
8.76
-0.32 (-3.52%)
At close: Nov 15, 2022, 6:00 AM

Company Description

Landec Corporation, together with its subsidiaries, designs, develops, manufactures, and sells differentiated health and wellness products for food and biomaterials markets in the United States and internationally.

It operates through Lifecore, Curation Foods, and Other segments.

The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures.

It also provides services, including technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products.

This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets.

The Curation Foods segment engages in processing, marketing, and selling of olive oils and wine vinegars under the O brand; and guacamole and avocado food products under the Yucatan and Cabo Fresh brands, as well as various private labels.

Landec Corporation was incorporated in 1986 and is headquartered in Santa Maria, California.

Landec Corporation
Landec Corporation logo
Country United States
IPO Date Feb 16, 1996
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 689
CEO Albert Bolles

Contact Details

Address:
5201 Great America Pkwy Ste 232
Santa Clara, California
United States
Website https://www.landec.com

Stock Details

Ticker Symbol LNDC
Exchange NASDAQ
Fiscal Year June - May
Reporting Currency USD
CIK Code 0001005286
CUSIP Number 514766104
ISIN Number US5147661046
Employer ID 94-3025618
SIC Code 2834

Key Executives

Name Position
James G. Hall Chief Executive Officer, Pres & Director
John D. Morberg Chief Financial Officer & Sec.
Aaron Perlitsh Director of Internal Audit & Chief Compliance Officer
Dr. Albert D. Bolles Ph.D. Pres of Curation Foods, Inc.
Parker K. Javid Vice President

Latest SEC Filings

Date Type Title
May 29, 2025 SCHEDULE 13D/A [Amend] Filing
May 28, 2025 4 Filing
May 22, 2025 4 Filing
May 16, 2025 4 Filing
May 12, 2025 4 Filing
May 07, 2025 4 Filing
Apr 16, 2025 8-K Current Report
Apr 16, 2025 4 Filing
Apr 16, 2025 3 Filing
Apr 10, 2025 8-K Current Report